Hypophosphatemia after iron infusion : can we still ignore it ?

The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revue médicale suisse 2020-03, Vol.16 (687), p.592-595
Hauptverfasser: Scardia, Stefano, Bonny, Olivier, Favre, Lucie
Format: Artikel
Sprache:fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 595
container_issue 687
container_start_page 592
container_title Revue médicale suisse
container_volume 16
creator Scardia, Stefano
Bonny, Olivier
Favre, Lucie
description The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2384215112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384215112</sourcerecordid><originalsourceid>FETCH-LOGICAL-p563-4b9b7c8509007f8e922b48faf904abbaccefb112c305e1d04475612027038b003</originalsourceid><addsrcrecordid>eNo1j81KAzEYRbNQbKl9BcnSzUD-JpO4ESlqhYKb7ock_WIjM5OYzCDdufFFfRIHrHdzFvdw4V6gJZWSVJo3eoHWpbyTOZJyxvgVWsygkiq-RJvtKcV0jCUdzQh9MNj4ETIOOQ44DH4qIQ4_X9932JkBfwIuY-g6HN6GmAGHca7ur9GlN12B9ZkrtH963G-21e71-WXzsKtSLXklrLaNUzXRhDRegWbMCuWN10QYa41z4C2lzHFSAz0QIZpaUkZYQ7iyhPAVuv2bTTl-TFDGtg_FQdeZAeJUWsaVYLSeJ2b15qxOtodDm3LoTT61_7_5L7f2VCo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2384215112</pqid></control><display><type>article</type><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</creator><creatorcontrib>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</creatorcontrib><description>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</description><identifier>ISSN: 1660-9379</identifier><identifier>PMID: 32216183</identifier><language>fre</language><publisher>Switzerland</publisher><subject>Administration, Intravenous ; Humans ; Hypophosphatemia - chemically induced ; Hypophosphatemia - prevention &amp; control ; Iron - administration &amp; dosage ; Iron - adverse effects ; Phosphates - metabolism</subject><ispartof>Revue médicale suisse, 2020-03, Vol.16 (687), p.592-595</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32216183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scardia, Stefano</creatorcontrib><creatorcontrib>Bonny, Olivier</creatorcontrib><creatorcontrib>Favre, Lucie</creatorcontrib><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><title>Revue médicale suisse</title><addtitle>Rev Med Suisse</addtitle><description>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</description><subject>Administration, Intravenous</subject><subject>Humans</subject><subject>Hypophosphatemia - chemically induced</subject><subject>Hypophosphatemia - prevention &amp; control</subject><subject>Iron - administration &amp; dosage</subject><subject>Iron - adverse effects</subject><subject>Phosphates - metabolism</subject><issn>1660-9379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KAzEYRbNQbKl9BcnSzUD-JpO4ESlqhYKb7ock_WIjM5OYzCDdufFFfRIHrHdzFvdw4V6gJZWSVJo3eoHWpbyTOZJyxvgVWsygkiq-RJvtKcV0jCUdzQh9MNj4ETIOOQ44DH4qIQ4_X9932JkBfwIuY-g6HN6GmAGHca7ur9GlN12B9ZkrtH963G-21e71-WXzsKtSLXklrLaNUzXRhDRegWbMCuWN10QYa41z4C2lzHFSAz0QIZpaUkZYQ7iyhPAVuv2bTTl-TFDGtg_FQdeZAeJUWsaVYLSeJ2b15qxOtodDm3LoTT61_7_5L7f2VCo</recordid><startdate>20200325</startdate><enddate>20200325</enddate><creator>Scardia, Stefano</creator><creator>Bonny, Olivier</creator><creator>Favre, Lucie</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200325</creationdate><title>Hypophosphatemia after iron infusion : can we still ignore it ?</title><author>Scardia, Stefano ; Bonny, Olivier ; Favre, Lucie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p563-4b9b7c8509007f8e922b48faf904abbaccefb112c305e1d04475612027038b003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2020</creationdate><topic>Administration, Intravenous</topic><topic>Humans</topic><topic>Hypophosphatemia - chemically induced</topic><topic>Hypophosphatemia - prevention &amp; control</topic><topic>Iron - administration &amp; dosage</topic><topic>Iron - adverse effects</topic><topic>Phosphates - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scardia, Stefano</creatorcontrib><creatorcontrib>Bonny, Olivier</creatorcontrib><creatorcontrib>Favre, Lucie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revue médicale suisse</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scardia, Stefano</au><au>Bonny, Olivier</au><au>Favre, Lucie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypophosphatemia after iron infusion : can we still ignore it ?</atitle><jtitle>Revue médicale suisse</jtitle><addtitle>Rev Med Suisse</addtitle><date>2020-03-25</date><risdate>2020</risdate><volume>16</volume><issue>687</issue><spage>592</spage><epage>595</epage><pages>592-595</pages><issn>1660-9379</issn><abstract>The occurrence of hypophosphatemia after iron infusion has been known for a long time but has only recently led to clinical concerns. It was considered to be of low clinical importance. The elucidation of the physiological mechanisms responsible for this effect, involving FGF23 and the ever-increasing number of cases with regard to the potentially very serious consequences on bone metabolism have recently raised probably justified concerns. In this article, we summarize the mechanisms of phosphate homeostasis, how intravenous iron can induce a phosphate deficiency and what precautions and treatments needs to be undertaken to prevent it.</abstract><cop>Switzerland</cop><pmid>32216183</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1660-9379
ispartof Revue médicale suisse, 2020-03, Vol.16 (687), p.592-595
issn 1660-9379
language fre
recordid cdi_proquest_miscellaneous_2384215112
source MEDLINE; Alma/SFX Local Collection
subjects Administration, Intravenous
Humans
Hypophosphatemia - chemically induced
Hypophosphatemia - prevention & control
Iron - administration & dosage
Iron - adverse effects
Phosphates - metabolism
title Hypophosphatemia after iron infusion : can we still ignore it ?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A15%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypophosphatemia%20after%20iron%20infusion%E2%80%85:%20can%20we%20still%20ignore%20it%E2%80%85?&rft.jtitle=Revue%20m%C3%A9dicale%20suisse&rft.au=Scardia,%20Stefano&rft.date=2020-03-25&rft.volume=16&rft.issue=687&rft.spage=592&rft.epage=595&rft.pages=592-595&rft.issn=1660-9379&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2384215112%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2384215112&rft_id=info:pmid/32216183&rfr_iscdi=true